Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strs Ohio decreased its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,255 shares of the biopharmaceutical company’s stock after selling 977 shares during the quarter. Strs Ohio’s holdings […]
Concord Wealth Partners lowered its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 82.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 60 shares of the biopharmaceutical company’s stock after selling 291 shares during the quarter. Concord Wealth Partners’ […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Friday. REGN has been the topic of a number of other research reports. Raymond James raised shares of Regeneron Pharmaceuticals from a “market perform” […]
Grandfield & Dodd LLC grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.4% in the third quarter, HoldingsChannel.com reports. The fund owned 32,242 shares of the biopharmaceutical company’s stock after purchasing an additional 763 shares during the period. Regeneron Pharmaceuticals accounts for about 1.9% of Grandfield & Dodd LLC’s […]
Mn Services Vermogensbeheer B.V. lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 52,500 shares of the biopharmaceutical company’s stock after acquiring an additional 1,300 shares during the period. Mn […]